Diabetes Mellitus: A Medical History Journey

Donald E. Greydanus, MD
Department of Pediatric and Adolescent Medicine, Western Michigan University School of Medicine, Kalamazoo, MI, USA

Joav Merrick, MD, MMedSci, DMSc,
Division of Adolescent Medicine, KY Children’s Hospital, Department of Pediatrics, Lexington, Kentucky, USA
National Institute of Child Health and Human Development, Jerusalem, Israel
Division of Pediatrics, Hadassah Hebrew University Medical Centers, Mt Scopus Campus, Jerusalem, Israel
School of Public Health, Georgia State University, Atlanta, Georgia, USA

Series: Public Health: Practices, Methods and Policies
BISAC: MED027000

Clear

$95.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

It is estimated that 86 million adult Americans have prediabetes and with that, a risk of developing T2DM (type 2 diabetes) within one in ten patients. About 29 million people have actual diabetes, most with T2DM. It was estimated in 2012 that about 208,000 people under the age of 20 have diabetes in the United States, but there is little data available on the prevalence of diabetes in the adolescent population. A recent study looking at 12-19 year olds from 2005-2014 found the prevalence of diabetes at 0.8%, with 28.5% undiagnosed and the prevalence of prediabetes 17.7%, more common among boys (22%) than girls (13.2%). With about 9% of the total US population having diabetes, this a public health issue of considerable proportions. In this book, the reader embarks on a journey through the medical history of the discovery and treatment of diabetes mellitus. It is the story of the human mind steadfastly seeking to understand its world — a story worth telling again and again — that has saved millions of lives from a premature death of misery in the 20th and now 21st century. (Imprint: Nova Biomedical)

Introduction

Chapter 1. Trends in Child and Youth Diabetes

Section One: Diabetes Mellitus History

Chapter 2. A Historical Journey of Diabetes Mellitus

Section Two: Acknowledgements

Chapter 3. About the Authors

Chapter 4. About the Department of Pediatric and Adolescent Medicine, Western Michigan University Homer Stryker MD School of Medicine (WMED), Kalamazoo, Michigan, United States

Chapter 5. About the National Institute of Child Health and Human Development in Israel

Chapter 6. About Book Series "Public Health: Practices, Methods and Policies”

Section Three: Index

Index

Chapter 1

[1] Bocarro JN, Floyd MF, Smith WR, Edwards MB, Schultz CL, Baran P, et al. Social and environmental factors related to boys' and girls' park-based physical activity. Prev Chronic Dis 2015 Jun 18;12:E97. Doi: 10.5888/pcd12.140532.
[2] Halonen JI, Stenholm S, Pentti J, Kawachi I, Subramanian SV, Kivimäki M, et al. Childhood psychosocial adversity and adult neighborhood disadvantage as predictors of cardiovascular disease: A cohort study. Circulation 2015 Jun 11. pii: CIRCULATIONAHA.115.015392. [Epub ahead of print].
[3] Duran AC, de Almeida SL, Latorre MD, Jaime PC. The role of the local retail food environment in fruit, vegetable and sugar-sweetened beverage consumption in Brazil. Public Health Nutr 2015 Jun 9:1-10. [Epub ahead of print].
[4] Christine PJ, Auchincloss AH, Bertoni AG, Carnethon MR, Sanchez BN, Moore K, et al. Longitudinal associations between neighborhood physical and social environments and incident type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA). JAMA Intern Med 2015 Jun 29. Doi: 10.1001/jamainternmed.2015.2691. [Epub ahead of print].
[5] Diez-Roux AV. Neighborhoods and health: Where are we and were do we go from here? Rev Epidemiol Sante Publique 2007;55(1):13-21.
[6] Centers for Disease Control and Prevention. National diabetes statistics report: Estimates of diabetes and its burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services, 2014.
[7] Lipman TH, Chang Y, Murphy KM. The epidemiology of type 1 diabetes in children in Philadelphia 1990-1994: evidence of an epidemic. Diabetes Care 2002;25(11):1969-75.
[8] National Diabetes Education Program (NDEP). Oerview of diabetes in children and adolescents. Bethesda, MD: NIH, CDC, 2014.
[9] Silverstein J, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005;28(1):186-212.
[10] American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000;23(3):381-9.
[11] Copeland KC, Silverstein J, Moore KR, Prazar GE, Raymer T, Shiffman RN, et al. Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents. Pediatrics 2013;131(2):364-82.
[12] American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl 1):S14-80.
[13] Menke A, Casagrande S, Cowie CC. Prevalence of diabetes in adolescents age 12 to 19 years in the United States, 2005-2014. JAMA 2016; 316(3):344.


[14] Center for Disease Control and Prevention. National diabetes month-November 2015. MMWR 2015;65(45):1261.

Chapter 2

[1] Early modern homo sapiens. URL: http://anthro.palomar.edu/homo2/mod_homo_4.htm.
[2] Magner LN. A history of the life sciences, 3rd ed. New York: Marcel Dekker, 2002.
[3] Kramer SN. The Sumerians. Chicago: The University of Chicago Press, 1963:225-6.
[4] Jastrow M. The liver in antiquity and the beginnings of anatomy. Tranasactions Coll Physicians 1907;XXIX:117.
[5] Roth MT. Law collections from Mesopotamia and Asia Minor. Atlanta, GA: Scholars Press, 1997.
[6] Geller MJ, Horstmanshoff HFJ, Stol M, Tilburg C, eds. West Meets East: Early Greeks and Babylonian diagnosis. Magic and rationality in ancient Near Eastern and Graeco-Roman Medicine. Boston, MA: Brill Publishers, 2004.
[7] Taylor JH, ed. Ancient Egyptian book of the dead: Journey through the afterlife. London: British Museum Press, 2010:54.
[8] Hallmann-Mikolajczak A. Ebers papyrus. The book of the medical knowledge of the 16th century BC Egyptians. Arch Hist Filoz Med 2004;67(1):5-14. [Polish].
[9] Stiefel M, Shaner A, Schaefer SD. The Edwin Smith papyrus: The birth of analytical thinking in medicine and otolaryngology. Laryngoscope 2006;116(2):182-8.
[10] Zajac J, Shrestha A, Patel P, Poretsky L. The main events in the history of diabetes mellitus. In: Poretsky L, ed. Principles of diabetes mellitus. New York: Springer Science, 2002:1-16.
[11] Loukas M, Lanteri A, Ferrauiola J, Tubbs RS, Maharaja G, Shoja MM, et al. Anatomy in ancient India: a focus on the Susruta Samhita. J Anat 2010;217(6):646-50.
[12] Frank LL. Diabetes mellitus in the texts of old Hindu medicine (Charaka, Susruta, Vagbhata). Am J Gastroenterol 1957;27(1):76-95.
[13] Sharma HS, Sharma HI, Sharma HA. Sushruta-samhitA: A critical review part-I: historical glimpse. Ayu 2012;33(2):167-73.
[14] Codellas PS. Alcmaeon of Croton: his life, work, and fragments. Proceed Royal Soc Med 1931;25(4):1041-6.
[15] Schiefsky MJ. Hippocrates: On ancient medicine. Leiden, Netherlands: Brill Publishers, 2005.
[16] Unguru S, Fried MN. Apollonius, Davidoff, Rorty, and Zeuthen: from A to Z, or, what else is there? Sudhoffs Arch 2007;91(1):1-19.
[17] André J. Remarks on the translation of Greek words into medical texts of the fifth century (Cassius Felix et Caelius Aurelianus). Rev Philol Litt Hist Anc 1963;37:47-67. [French].
[18] Coturri E. Surgery in Aurelianus Caelius [Vari XXXX]. Minerva Med 1959;50(35):Varia 898-914. [Italian].
[19] Saba MM, Ventura HO, Saleh M, Mehra MR. Ancient Egyptian medicine and the concept of heart failure. J Card Fail 2006;12(6):416-21.
[20] Van Praagh R, Van Praagh S. Aristotle’s “triventricular” heart and the relevant history of the cardiovascular system. Chest 1983;84(4):462-8.
[21] Loukas M, Hanna M, AlsaieMason Stephen F. gh N, Shoja MM, Tubbs RS. Clinical anatomy as practiced by ancient Egyptians. Clin Anat 2011;24(4):409-15.
[22] Witters LA, Luciano M, Williams C, Yang J. Diabetes detectives. Dartmouth Med 2008;Winter:1-2.
[23] Wilson JC. Aulus Cornelius Celsus and some remarks concerning rare editions of old books and medical libraries. Bull Med Libr Assoc 1913;3(1):1-10.
[24] Androutsos G. Urology in the work De re medical of Aulus Cornelius Celsus (1st century AD). Prog Urol 2005;15(2):344-52. [French].
[25] Trancas B, Borja Santos N. Ethics, knowledge and psychiatry: in Aulus Cornelius Celsus’ De Medicina. Acta Med Port 2007;20(5):431-7. [Portuguese].
[26] Finlayson J. Galen: [A bibliographical demonstration in the library of the faculty of physicians and surgeons of Glasgow, December 9th, 1891.]. Br Med J 1892;1(1628):573-5.
[27] Kempf EJ. From Hippocrates to Galen. Med Library Hist J 1904;2(4):282-307.
[28] Larkey SV. Galen: Greek, medievalist and modern: Part II. Cal West Med 1931;34(5):366-9.
[29] Hankinson RJ. Galen on Hippocratic physics. Stud Anc Med 2016;46:421-43.
[30] Kühn CG, ed. Claudii Galeni Opera Omnia. Leipzig: C Cnobloch, 1821.
[31] Bujalkova M. Rufus of Ephesus and his contribution to the development of anatomical nomenclature. Acta Med Hist Adriat 2011;9(1):89-100.
[32] Eknoyan G. Rufus of Ephesus and his “Diseases of the kidneys.” Nephron 2002;91(3):383-90.
[33] Adams F, ed. Arataeus the Cappadocian: the extant works. London: Sydenham Society, 1856.
[34] Roselli A. Arataeus of Cappadocia’s reading of the Hippocratic Corpus. Stud Anc Med 2005;31:413-32. [Italian].
[35] Laios K, Karamanou M. Saridaki Z, Androutsos G. Arataeus of Cappadocia and the first description of diabetes. Hormones (Athens) 2012;11(1):109-13.
[36] Garcia-Albea Ristol E. Arataeus of Cappadociaa (2nd century D) and the earliest neurological descriptions. Rev Neurol 2009;48(6):322-7. [Spanish].
[37] Tekiner H. Arataeus of Cappadocia and his treatises on diseases. Turk Neurosurg 2015;25(3):508-12.
[38] Reed JA. Arataeus the Cappadocian: History enlightens the present. Diabetes 1954;3:419-21.
[39] Greydanus DE, Hofmann AD. Psychological factors in diabetes mellitus: a review of the literature with emphasis in adolescence. Am J Dis Child 1979;133:1061-6.
[40] Cordell EF. Arateus of Cappadocia. Bull Johns Hopkins Hosp 1909;20:371-7.
[41] Pearce JMS. The neurology of Arateus: Radix pedis neuralgia. Eur Neurol 2013;106-112.
[42] Bongartz LG, Cramer J, Joles JA. Origins of the cardiorenal syndrome and the cardiorenal connection. Chronic Kidney Disease. URL: http://cdn..intechopen.com/pdfs-wm/32307/pdf.
[43] Kirchhof M, Popat N, Malowany J. A historical perspective of the diagnosis of diabetes. Univ West Ontario Med J 2008;78(1):1-4.
[44] Guthrie DW, Humpheys SS. Diabetes urine testing: an historical perspective. Diabetes Educ 1988;14(6):521-6.
[45] Laron Z. Childhood diabetes towards the 21st century. J Pediatr Endocrinol Metabol 1998;11(3):387-402.
[46] Karamanou M, Protogerou A, Tsoucalas G, Androutsos G, Poulakou-Rebelakou E. Milestones in the history of diabetes mellitus: The main contributors. World J Diabetes 2016;7(1):1-7.
[47] Bestetti RB, Baraldi C, Restini BA, Couto LB. Development of anatomophysiologic knowledge regarding the cardiovascular system: from Egyptians to Harvey. Arq Bras Cardiol 2014;103(6):538-45.
[48] Christopoulou-Aletra H, Papavramidou N. ‘Diabetes’ as describe by Byzantine writers from the fourth to the ninth century AD: the Graeco-roman influence. Diabetologia 2008;51(5):892-6.
[49] Baldwin B. The career of Oribasius. Acta Cl 1975;18:85-97.
[50] Riou YF. Un fragment d’un manuscript disparu d’Oribase, C.L.A. 116 (Vatican, Urb. lat. 293, ff. 95-96, VIIIe siècle). Scriptorium 1979;33:235-7.
[51] Lascaratos J, Poulakou-Rebelakou E. Oribasius (fourth Century) and early Byzantine perinatal nutrition. J Pediatr Gastroenterol Nutr 2003;36(2):186-9.
[52] Mikic Z. Famous physicians from the past—Oribasisus from Pergamum. Med Pregl 2013;66(3-4):189-92. [Serbian].
[53] Shirodkar JA, Sayyad MG, Nanal VM, Yajnik CS. Anguli parimana in Ayurveda and its association with adiposity and diabetes. J Ayurveda Integr Med 2014;5(3):177-84.
[54] Irmer D. Bearbeitungen von Schriften des iatrosophisten palladius unter den namen des Johannes, Stephanus, und Theophilus. Medizinhist J 1973;8(2-3):179-81. [German].
[55] Papathanassiou MK. Stephanus of Alexandria: pharmaceutical notions and cosmology in his alchemical work. Ambix 1990;37(3):121-33.
[56] Papathanassiou MK. Stephanus of Alexandria; on the structure and date of his alchemical work. Med Secoli 1996;8(2):247-66.
[57] Bouras-vallianatos P. Clinical experience in late antiquity: Alexander of Tralles and the therapy of epilepsy. Med Hist 2014;58(3):337-53.
[58] Puschmann T. Nachträge zu Alexander Trallianus. Fragmente aus philumenus und philagrius, nebst einer Bisher noch ungedruckten abhandlung über augenkrankheiten. Berlin: Verlag von S Calvary, 1886. [German].
[59] Delisle L, Le cabinet des manuscrits de la Bibliothèque nationale, 4 tomes, Paris, Imprimerie Nationale, 1868-1891 (réimpression 1978).
[60] Ongaro G. Le conoscenze elmintologiche de Alessandro di Tralle. Acta Med Hist Patav 1964-5;11:119-43. [Italian].
[61] Nutton V.The Latin Alexander Trallianus: the text and transmission of a Latin medical book (review). Bull Hist Med 2009;83(2):388-9.
[62] Papavramidou N, Christopoulou-Aletra H. Greco-Roman and Byzantine views on obesity. Obes Surg 2007;17(1):112-6.
[63] Mylonas AI, Poulakou-Rebelakou EF, Androutsos GI, Seggas I, Skouteris CA, Papadopoulou EC. Oral and cranio-maxillofacial surgery in Byzantium. Craniomaxillofac Surg 2014;42(2):159-68.
[64] Poulakou-Rebelakou E, Marketos SG. Kidney disease in Byzantine medical texts. Am J Nephrol 1999;19(2):172-6.
[65] Diamandopoulos A. Twelve centuries of nephrological writings in the Graeco-Roman world of the Eastern Mediterranean (from Hippocrates to Aetius Amidanus). Nephrol Dial Transplant 1999;14(Suppl 2):2-9.
[66] Scarborough J. Teaching surgery in late Byzantine Alexandria. Stud Anc Med 2010;35:235-60.
[67] Sideras A. Aetius und Oribasius: Ihre gemeinsamen Exzerpte aus der Schrift des Rufus von Ephesos “Ueber die Nieren- und Blasenleiden” und ihr Abhängigkeitsverhältnis. Byzantinische Z 1974;67:110-30. [German].
[68] Conti Bizzarro F. Per l’edizione dei libri medicinali di Aezio Amideno. Koinonia 1978;2:169-97. [Italian].
[69] Durling RJ. Addenda lexicis, primary from Aëtius of Amida and Paul of Aegina. Glotta 1986;44(1-2):30-6.
[70] Lascaratos J, Tsirou M, Fronimopoulos J. Ophthalmology according to Aetius Amidenus. Doc Ophthalmol 1990;74(1-2):37-48.
[71] Karenberg A, Hort I. Medieval descriptions and doctrines of stroke: preliminary analysis of select sources. Part I: The struggle for terms and theories—late antiquity and early Middle Ages. J Hist Neurosci 1998;7(113 Pt 2):162-73.
[72] Gamillscheg E. Copyists of manuscripts for medicine. Med Secoli 1999;11(3):477-86. [German]
[73] Ramoutsaki IA, Dimitriou H, Kalmanti M. Management of childhood diseases in the Byzantine period: I—analgesia. Pediatr Int 2002;44(3):335-7.
[74] Bieganowski L. Ophthalmology in Byzantium between the 4th and the 7th century. Klin Oczna 2005;107(1-3):177-81. [Polish]
[75] Mylonas AI, Poulakou-Rebelakou EF, Androutsos GI, Seggas I, Skouteris CA, Papadopoulou EC. Oral and cranio-maxillofacial surgery in Byzantium. J Craniomaxillofac Surg 2014;42(2):159-68.
[76] Francis A. The medical works of Paulus Aegineta, the Greek physician: Translated into English with a copious commentary containing a comprehensive view of the knowledge possessed by the Greeks, Romans, and Arabians, on all subjects connected with medicine and surgery. First Edition. London: Welsh Treuttel Würtz, 1834. Book found in the collections of Oxford University. URL: https://archive.org/details/medicalworkspau00paulgoog.
[77] Pormann PE. The oriental tradition of Paul of Aegina’s Pragmateia. Stud Anc Med 2004;29:1-337.
[78] Coturri E. Considerations on the surgical doctrinaire of Paul of Aegina. Minerva Med 1959;50:1665-8. [Italian].
[79] Gurunluoglu R, Gurunluoglu A. Paulus Aegineta, a seventh century encyclopedist and surgeon: his role in the history of plastic surgery. Plast Reconstruc Surg 2001;108(7):2072-9.
[80] Lascaratos J, Cohen M. Paul of Aegina. Plast Reconstr Surg 2002;110(5):1600-1.
[81] Papadakis M, de Bree E, Trompoukis C, Manios A. Paul of Aegina’s surgical instruments: a complete surgical instrumentarium in the seventh century AD. Anz J Surg 2015 Mar 2. doi:10.1111/ans.13027.
[82] Peumery JJ. Histoire illustrée du diabète. De l’Antiquitéa nos jours. Paris: Roger Dacosta, 1987.
[83] Eknoyan G, Naby J. A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease. Adv Chronic Kidney Dis 2005;12(2):223-9.
[84] Needham J, Lu G-D. Proto-endocrinology: Medieval preparations of urinary steroid and protein hormones. Science and Civilization in China, Volume 5: Chemistry and chemical technology, Part 5: Spagyrical discovery and invention. Physiological alchemy, Cambridge, UK: Cambridge University, 1983:301-37.
[85] Androutsos G. Theophilus Protospatharius: Byzantine forerunner of urology. Hist Sci Med 2007;41(1):41-8. [French].
[86] Gorgieva GS. Kidney disease in medieval Serbian manuscripts from the Chilandar monastery (Mount Athos, Greece). J Nephrol 2006;19(Suppl 10):S30-7.
[87] Iorio L, Lamagna M. Foam in urine: from Hippocrates to the medical school of Salerno. G Ital Nefrol 2014;31(2). pii: gin/31.2.14. [Italian]
[88] Theophilus: De urinis. Édition gréco-latine. Traduction par Thomas Guidot, 1703.
[89] Touwaide A. Sephanus of Athens. The encyclopedia of ancient history, 2012. doi: 1002/9781444338386.wbeah21306.
[90] Nutton V. Stepanus of Athens, Commentary on Hippocrates’ Aphorisms, Section 1-2, Corpus Medicorum Graecorum XI 1,3,1. Med Hist 1986;30(2):228-9.
[91] Westerink Leendert G, ed. Stepanus of Athens, Commentary on Hippocrates’ Aphorisms, Section III-IV, Corpus Medicorum Graecorum XI 1,3,2. Berlin: Akademie Verlag, 1992.
[92] Westerink Leendert G, ed. Stepanus of Athens, Commentary on Hippocrates’ Aphorisms, Section V-VI, Corpus Medicorum Graecorum XI 1,3,3. Berlin: Akademie Verlag, 1995.
[93] Garofalo I. The Arabic translations of Alexandrian compendia of the works of Galen’s Canon. The ad glauconem compendium. Med Secoli 1994;6(2):329-48. [Italian].
[94] Angeletti LR, Cavarra B. The Peri ouron treatise of Stephanus of Athens: Byzantine uroscopy of the 6th-7th centuries AD. Am J Nephrol 1997;17(3-4):228-32.
[95] Flaws B, L Kurchinski L, Casanas RJ. The treatment of diabetes mellitus with Chinese medicine: A textbook and clinical manual. Boulder, CO: Blue Poppy Press, 2002.
[96] Bowersock G. The vanishing paradigm of the Fall of Rome. Bull Amer Acad Arts Sciences 1996;49(8):29–43.
[97] Masic I, Dilic M, Solakovic E, Rustemepasic N, Ridjanovic Z. Why historians of medicine called Ibn al-Nafis the second Avicenna? Med Arh 2008;62(4):244-9.
[98] Greydanus DE, Raj VMS, Merrick J. From the Kition, Cyprus and Aristotelian kidney to the 21st century pediatric kidney: standing on the shoulders of giants. In: Greydanus DE, Raj VMS, Merrick J, eds. Chronic illness and disability: The pediatric kidney. New Yok: Nova Biomedical, 2016:3-26.
[99] Eknoyan G. Arabic medicine and nephrology. Am J Nephrol 1994;14:270-8.
[100] Changizi Astivani S, Shamsi M, Cyrus A, Bastani B, Tabatabayei SM. A critical review of the works of pioneer physicians on kidney diseases in ancient Iran: Avicenna, Rhazes, Al-akhawayni, and Jorjani. Iran J Kidney Dis 2011;5(5):300-8.
[101] Dunea G. History of nephrology: beginnings. Hektoen Internat: J Med Humanities. URL: http://www.hektoeninternational.org/index/php?option=com.
[102] Muntner Z. Persian medicine and its relation to Jewish and other medical science; commemorating the millennium of Avicenna. Harofe Haivri Heb Med J 1951;2:171-6.
[103] Chamsi-Pasha MAR, Chamsi-Pasha H. Avicenna’ contribution to cardiology. Avicenna J Med 2014;4(1):9-12.
[104] Faridi P, Zarshenas MM. Ibn Sina’s book on drugs for cardiovascular diseases. Int J Cardiol 2010;145:223.
[105] Tekol Y. The medieval physician Avicenna used an herbal calcium channel blocker, Taxus baccata L. Phytother Res 2007;21:701-2.
[106] Eknoyan G. A history of diabetes mellitus—a disease of the kidneys that became a kidney disease. J Nephrol 2006;19(Suppl 10):S71-4.
[107] The history of diabetes. URL www.med.uni-giessen.de/itr/history/diabhis.html.
[108] Majeed A. How Islam changed medicine. BMJ 2005;331:1486-7.
[109] West JB. Ibn al-Nafis, the pulmonary circulation, and the Islamic Golden age. J Appl Physiol 1985;105(6):1877-80.
[110] Siahpoosh M, Ebadiani M, Shah Hosseini G, Isafhani M, Nasrabadi AN, Dadgostar H. Avicenna the first to describe diseases which may be prevented by exercise. Iran J Public Health 2012;41(11):98-101.
[111] Osler W. Suggested scheme for the restoration of the Tomb of Avicenna. Proc R Soc Med 1914;7(Sect Hist Med):280.
[112] O’sullivan PM. The Canon Medicinae of Avicenna. Bull Med Libr Assoc 1928;17(3):14-5.
[113] Lichtwardt HA. Avicenna—philosopher and genius, teacher and surgeon. J Mich State Med Soc 1950;49(5):568-72.
[114] Weaver AD. Avicenna, 980-1037. Works in the library of the New York Academy of Medicine. Bull NY Acad Med 1955;31(4):334.
[115] Huard P. Avicenne (980-1037); Abou Ali al-Housayn ibn-Abdoullah ibn-Sina. Concours Med 1956;78(50):5357-63. [French].
[116] Galdston I. Avicenna and Islamic science. Bull NY Acad Med 1955; 31(4): 300-1.
[117] Levy R. Avicenna—his life and times. Med Hist 1957;1(3):249-61.
[118] Kuprilanov VV. Outstanding contribution of the works of Avicenna to the history of anatomy (on the occasion of the 1,000th anniversary of the birth of Avicenna). Arkh Anat Gistol Embriol 1980;79(9):109-11. [Russian].
[119] Mannan AA, Kahvic M. Ibn Sina: a tribute. Gulf J Oncolog 2010;(7):60-3.
[120] Shamsi M, Haghverdi F, Changizi Ashtiyani S. A brief review of Rhazes, Avicenna, and Jorjani’s views on diagnosis of diseases through urine examination. Iran J Kidney Dis 2014;8(4):278-85.
[121] Bittar EE. A study of Ibn Nafis. Bull Hist med 1955;29:352-68.
[122] Coppola ED. The discovery of the pulmonary circulation: a new approach. Bull Hist Med 1957;31:44-77.
[123] Masic I, Dilic M, Solakovic E, Rustemepasic N, Ridjanovic Z. Why historians of medicine called Ibn al-Nafis the second Avicenna? Med Arh 2008;62(4):244-9.
[124] Masic I. On the occasion of 800th anniversary of birth of Ibn al-Nafis—discoverer of cardiac and pulmonary circulation. Med Arh 2010;64(5):309-13.
[125] Akmal M, Zulkifle M, Ansari A. Ibn Nafis—a forgotten genius in the discovery of pulmonary blood circulation. Heart Views 2010;11(1):26-30.
[126] Rodin FH. Moses Maimonides: Great physician, scientist, and philosopher. Cal West Med 1936;44(3):192-6.
[127] Barr SE. Moses Maimonides. N Engl J Med 154;250(18):779-80.
[128] Rosner F. Nephrology and urinalysis in the writings of Moses Maimonides. Am J Kidney Dis 1994;24:222-7.
[129] Gesundheit B. Maimonides’ appreciation for medicine. Rambam Maimonides Med J 2011;2(1):e0018. doi: 10.5041/RMMJ.10018.
[130] Connor H. Moses Maimonides (1135-1204). J Med Biogr 2009;17(1):13. doi: 10.1258/jmb.2008.008005.
[131] Cantwell JD. On camel rides and Moses Maimonides. Proc (Bayl Univ Med Cent). 2015;28(3):406-8.
[132] Rosner F, Muntner S. Moses Maimonides’ aphorisms regarding analysis of urine. Ann Intern Med 1969;71(1):217-20.
[133] Massry SG. Maimonides: physician and nephrologist. Am J Neprhol 1994;14(4-6):307-12.
[134] Kaltenstadler W. Life is short, art is long: Medical works of Moses Maimonides. Dtsch Med Wochenschr 2010;135(51-52):2563-6. [German].
[135] Rosner F, Muntner S, eds. The medical aphorisms of Moses Maimonides. NewvYork: Yeshiva Universtiy Press, 1971.
[136] Eknoyan G. On the contributions of Paracelsius to nephrology. Nephrol Dial Transplant 1996;11:1138-94.
[137] Medvei VC. The 16th century and the Renaissance. In: Medvei VC, ed. The history of clinical endocrinology: A comprehensive account of endocrinology from earliest times to the present day. New York: Parthenon Publishing, 1993:55-6,97.
[138] Morley H. The life of Girolamo Cardano of Milan, Physician 2 volumes. London: Chapman Hall, 1854.
[139] Ongaro G. Girolamo Cardano and Andreas Vesalius. Riv Stor Med 1969;13(1):51-61. [Italian].
[140] Regöly-Mérei G. The life and scientific activity of Girolamo Cardano. Orv Hetil 1971;112(38):2291-3. [Hungarian].
[141] Simili A. The figure and work of Girolamo Cardano. Riv Stor Med 1970;14(1):3-18. [Italian].
[142] Scarani P. Out of control: the life of Gerolamo Cardano (1501-1576). Pathologica 2001;93(5):565-74. [Italian].
[143] Antonello A, Calo L, Bonfante L, Mennella G, Abaterusso C, Spinello M, et al. Giovanni Battista Morgagni, a pioneer of clinical nephrology. Am J Nephrol 1999;19:222-5.
[144] Fischer WJ. Thomas Sydenham, the English Hippocrates: (1624-1689). Can Med Assoc J 1913;3(11):931-46.
[145] No Authors listed. Thomas Sydenham (1624-1689). Can Med Assoc J 1924;14(10):983-4.
[146] Bloch H. Thomas Sydenham, MD (1624-1689): the father of clinical observation. J Fam Pract 1994;38(1):80-1.
[147] Low G. Thomas Sydenham: the English Hippocrates. Aust NZ J Surg 1999;69(4):258-62.
[148] Anstey P. The creation of the English Hippocrates. Med Hist 2011;55(4):457-78.
[149] Hamid A, Mohd A, Tanzeel A, Naghma C. Diabetes mellitus from antiquity to present scenario and contribution of Greco-Arab physicians. JISHIM 2006;5:46-50.
[150] Willis T. Pharmaceutice rationalis or an exercitation of the operations in humane bodies. London: Dring Harper Leigh, 1678.
[151] Willis T. Founders of modern medicine. I Thomas Willis, MA, MD (1621-1675). Med Library Hist J 1903;1(4):264-70.
[152] van Gijn J, Gijselhart JP. Willis and his circle. Ned Tijdschr Geneeskd 2012;156(12):A4653. [Dutch].
[153] Feindel W. Thomas Willis (1621-1675)-The founder of neurology. Can Med Assoc J 1962;87(6):289-96.
[154] Ahmed AM. History of diabetes mellitus. Saudi Med J 2002;23(4):373-8.
[155] Stylianou C, Kelnar C. The introduction of successful treatment of diabetes mellitus with insulin. J R Soc Med 2009;102(7):298-303.
[156] Allan FN. The writings of Thomas Willis, MD; Diabetes 300 years ago. Diabetes 1953;2(1):74-7.
[157] Greydanus DE, Hofmann AD. Psychological factors in diabetes mellitus. Am J Dis Child 1979;133:1061-6.
[158] Bosmia AN, Tubbs RI, Clapp DC, Batzdorf U, Loukas M, Tubbs RS. Johann Conrad Brunner (1653-1727) and the first description of syringomyelia. Child Nerv Syst 2014;30(2):193-6.
[159] Keck FS, Pfeiffer EF. The first experimental diabetes mellitus. Acta Diabetol Lat 1989;26(1):79-81.
[160] Brunner JC. Experimenta nova circa pancreas, accedit diatribe de lympha et gemino pancreatis usu. Amsterdam: Apud H Wetstenium, 1683.
[161] Keck FS, Duntas LH. Brunner’s missing ‘Aha experience’ delayed progress in diabetes research by 200 years. Hormones (Athens) 2007;6(3):251-4.
[162] Dobson M. Experiments and observations on the urine in diabetes. In: Medical Observations and Inquiries. Volume 5. London: T Cadell, 1776:298-316.
[163] Williamson RT. English physicians of the past. Newcastle: Andrew Reid, 1923:47-52.
[164] Polonsky KS. The past 200 years in diabetes. N Engl J Med 2012;367:1332-40.
[165] Furdell EL. Fatal thirst. Diabetes in Britain until insulin. Leiden, Netherlands: Brill, 2009:81-92.
[166] Sanders LJ. From Thebes to Toronto and the 21st century: an incredible journey. Diabetes Spectrum 2002;15(1):56-60.
[167] Kerr CE, Milne I, Kaptchuk TJ. William Cullen and a missing mind-body link in the early history of placebos. J R Soc Med 2008;101(2):89-92.
[168] Cawley TA. Singular case of diabetes, consisting entirely in the quality of urine; with an inquiry into the different theories of that disease. London Med J 1788;9:286-308.
[169] Longo LD. Classic pages in obstetrics and gynecology: an account of a particular change of structure in the human ovarium. Matthew Baillie, 1789. Am J Obstet Gynecol 1975;123(7):770.
[170] Young RH. The history of British gynaecological pathology. Histopathology. 2009;54(2):144-55.
[171] Somebody. The introduction of successful treatment of diabetes mellitus with insulin. R Soc Med 2009;102(7):298-303.
[172] Baillie M. The morbid anatomy of some of the most important parts of the human body, 2nd ed. London: J Johnvson, 1797.
[173] Rollo J. Causes of the diabetes mellitus, 2nd ed. London: C Dilly, 1798.
[174] Rollo J. An account of two cases of the diabetes mellitus,with remarks as they arose during the progress of the cure. London: C Dilly, 1797.
[175] Lemay P. Michel Eugene Chevreul (1786-1889). J Chem Educ 1948;25(2):62.
[176] Bourgougnon A. Michel Eugéne Chevreul. 1786-1889. J Am Chem Soc 1989;11(5):71-79.
[177] Chevreul ME. Note sur le sucre de diabetes. Ann Chim 1815;95:319-20.
[178] Fehling H. Die quantitative Bestimmung von Zucker und Stärkmehl mittelst Kupfervitriol. Ann Chemie Pharmacie 1849;72(1):106-13.
[179] Elliotson J. The principles and practice of medicine. London: J Butler, 1839.
[180] Ridgway ES. John Elliotson (1791-1868): a bitter enemy of legitimate medicine? Part II: The mesmeric scandal and later years. J Med Biogr 1994;2:1-7.
[181] Todd EM. An itinerant mermerist. Anaesth Intensive Care 2012;40(Suppl 1):5-9.
[182] Wittke G. Claude Bernard (1813-1878)-remarks on his methodology. Berl Munch Tierarztl Wochenschr 1994;107(2):37-42. [German]
[183] Jörgens V, Grüsser M. Happy birthday, Claude Bernard. Diabetes 2013;62(7):2181-2.
[184] Bernard C. Introduction ? l’étude de la Médecine Expérimentale. Paris: J-B Bailliére, 1865.
[185] Bernard C. De l’origine du sucre dans l’?conomie animale. Arch Gen Med 1848;18:303-319. [French].
[186] Foster M. Claude Bernard: a lecture. BMJ 1878;1(903):559-60.
[187] Rodriquez de Romo AC, Borgstein J Claude Bernard and fat emulsion (or the Sleeping Beauty 150 years later). Gac Med Mex 2000;136():379-86. [Spanish]
[188] Han KW. The formation and background of Claude Bernard’s general physiology. Uisahak 2010;19(2):507-52. [Korean].
[189] Noble D. Claude Benard, the first systems biologist, and the future of physiology. Exp Physiol 2008;93(1):16-26.
[190] Bernard C. Mémoire sur le pancréas et sur le rôle du suc pancréatique dans les phénomènes digestifs, particulièrement dans la digestion des matières grasses neutres. Comptes rendus hebdomadaires de l’Académie des sciences 1856;1:379–563.
[191] Friedman A. Fluid and electrolyte therapy: a primer. Pediatr Nephrol 2010;25(5):843-6.
[192] Harrison HE, Darrow DC, Yannet H. The total electrolyte content of animals and its probable relation to the distribution of body water. J Biol Chem 1936;113:515-29.
[193] Gamble JL. Chemical anatomy, physiology and pathology of extracellular fluid: a lecture syllabus. Boston, MA: Harvard University Press, 1947.
[194] Granger A, Kushner JA. Cellular origins of beta cell regeneration: a legacy view of historical controversies. J Intern Med 2009;266(4):326-38.
[195] Rosenfeld L. William Prout: early 19th century physician-chemist. Clin Chem 2003;49(4):699-705.
[196] Prout W. On the nature and treatment of stomach and renal diseases, 5th ed. London: Churchill, 1848.
[197] Brock WH. The life and work of William Prout. Med Hist 1965;9:101-26.
[198] No authors listed. William Prout (1785-1850) analytical chemist. JAMA 1968;206(5):1079-80.
[199] Copeman WS. William Prout, M.D., FRS. Physician and chemist (1785- 850). Notes Rec R Soc Lond 1970;24:273-80.
[200] No authors listed. William Prout (1785-1859). Nutrition classics: Philosophical Transactions of the Royal Society of London. For the year MDCCCXXVII. Part I. Volume CXVII:355-388, 1827. XXIII. On the ultimate composition of simple alimentary substances; with some preliminary remarks on the analysis of organized bodies in general. By William Prout. Nutr Rev 1975;33(4):112-4.
[201] Ahrens R. William Prout (1785-1850): a biographical sketch. J Nutr 1977; 107(1):17-23.
[202] Nwaneri C. Diabetes mellitus: a complete ancient and modern historical perspective. WebmedCentral Diabetes 2015;6(2):WMC004831.
[203] Kark RM. A propect of Richard Bright on the centenary of his death, December 16, 1958. Am J Nephrol 1958;6:819-24.
[204] Dock W. Proteinuria: the story of 280 years of trials, errors, and rectifications. Bull NY Acad Med 1974;50:659-66.
[205] Bright R. Reports of medical cases. Selected with a view of illustrating the symptoms and cure of diseases by a reference to morbid anatomy. London: Longman Rees Orme Brown Green, 1827.
[206] Weller RO, Nester B. Historical reassessment of three kidneys originally described by Richard Bright in 1827-36. BMJ 1972;2(5816):761-3.
[207] Dunea G. History of nephrology: the middle period. Hektoen Internat: J Med Humanities. URL: http://www.hektoeninternational.org/HON-beginnings.html.
[208] MacKenzie JC. Dr. Richard Bright—a man of many parts. His bicentenary year—1789-1858. Bristol Med Chir J 1989;104(3):63-7.
[209] Mukhin NA. Richard Bright and the nephrological theory of E.M. Tareev. Klin Med (Mosk) 1990;68(1):4-7. [Russian].
[210] Young RH. Dr. Richard Bright—father of medical renal disease. Arch Pathol Lab Med 2009;133(9):136.
[211] Apollinaire B. De la Glycosurie ou diabète sucré, son traitement hygénigue. Paris: Libraire Germer Bailliére, 1883.
[212] Bouchardat A. Nouveau mémoire sur la glycosurie. Comptes rendus des séances de l’Académie des sciences 1845;20:1020.
[213] Chast F. Apollinaire Bouchardat, pharmacist, nutritionist. Ann Pharm Fr 2000;58(6 Suppl):435-42. [French].
[214] Chast F, Slama G. Apollinaire Bouchardat and diabetes. Hist Sci Med 2007;41(3):287-301. [French].
[215] Trépardoux F, Ségal A. Bouchardat and hygienic medicine. Hist Sci Med 2007;41(3):279-86. [French].
[216] Karamanou M, Koutsilieris M, Laios K, Marineli F, Androutsos G. Apollinaire Bouchardat (1806-1886): founder of modern diabetology. Hormones (Athens) 2014;13(2):296-300.
[217] Lancereaux E. Note et réflexions sur deux cas de diabéte sucrè avec alteration du pancrèas. Bull Acad Med 1877;6:1215.
[218] Lancereaux E. Le diabéte maigre: ses symptomes, son évolution, son prognostic et son traitment; ses rapports avec les altérations du pancréas. Etude comparative du diabéte maigre et du diabéte gras. In: Delahaye A, Lecrosnier E, eds. Lecons de Clinique Médicale: Paris: 1883:5–16.
[219] Peumery JJ. Étienne Lancereaux (1829-1910) sa vie, son oeuvre, ses découvertes scientifiques. Hist Sci Med 1989;23(4):279-84.
[220] Lestradet H. The 75th anniversary of the discovery of insulin. Diabetes Metab 1997;23(1):112-7. [French].
[221] Leickert KH. Insulin precursors—a historical synopsis. First diabetes treatment trials using pancreatic extracts. Arzneimittelforschung 1975;25(3):439-42. [German].
[222] Wolf G. Friedrich Theodor von Frerichs (1819-1885) and Bright’s disease. Am J Nephrol 2002;22(5-6):596-602.
[223] No authors listed. Friedrich Theodor von Frerichs (1819-1885). JAMA 1963;186:511-2.
[224] Martini GA. Friedrich Theodor von Frerichs (1819-1885). Clinical picture of acute liver atrophy. Internist (Berl) 1969;10(3):74-8.
[225] Schwarz U, Ritz E. Glomerulonephritis and progression----Friedrich Theodor von Frerichs, a forgotten pioneer. Nephrol Dial Transplant 1997;12:2776-8.
[226] Thormann J, Steinberg H. Friedrich Theodor von Frerichs (1819-1885). J Neurol 2014;261(1):248-9.
[227] Young P, Finn BC, Bruetman JE, Buzzi A, Zylberman M. The outstanding achievements of Adolf Kussmaul. Rev Med Chil 2012;140(4):538-44. [Spanish].
[228] Hoffmann KF. Memories of the clinician Adolf Kussmaul (1822-1902); special reference to hydrotherapy. Hippokrates 1952;23(15):419-20.
[229] No authors listed. Adolf Kussmaul (1822-1902) – country doctor to clinical professor. JAMA 1964:189:54-9.
[230] Nogaller AM. Adolf Kussmaul (1822-1902) as a doctor, scientist, teacher. Klin Med (Mosk) 1999;77(6):63-4. [Russian].
[231] Johnson SK, Naidu RK, Ostopowicz RC, Kumar DR, Bhupathi S, Mazza JJ, et al. Adolf Kussmaul: distinguished clinician and medical pioneer. Clin Med Res 2009;7(3):107-12.
[232] Kussmaul A. Zur Lehre vom Bailliere. Uber eine eigenthumliche to desart bei Diabetischen, Uber Acetonamie. Glycerin-behandlung des Diabetes und Einspritzungen von Diastase ins blit bei dieser Kranicheit. Deutsche Arch Klin Med1874;14:1-46. [German]
[233] Breathnach CS, Westphal W. Adolf Kussmaul (1822-1902): from youth to maturity under the influence of Virchow. J Med Biogr 2003;11(1):55-61.
[234] Noyes HD. Retinitis in glycosuria. Trans Am Ophthalmol Soc 1869;4: 71-5.
[235] Kalantzis G, Angelou M, Poulakou-Rebelako E. Diabetic retinopathy: An historical assessment. Hormones 2006;5(1):71-4.
[236] Nettleship E. On oedema or cystic disease of the retinal. Roy Ophthal Lond Hosp Rep 1872;VII:343-41.
[237] Mackenzie S, Nettleship E. A case of glycosuric retinitis. Roy Ophth Lond Hosp Rep 1877;9:134.
[238] Lawford JB. British masters of ophthalmology series: Edward Nettleship FRS, FRCS (1845-1913) Br J Ophthalmol 1923;7:nil4-9. doi: 10.1136/bjo.7.1.nil4.
[239] Wolfensberger TJ, Hamilton AM. Diabetic retinopathy—an historical review. Semin Ophthalmol 2001;16(1):2-7.
[240] Naunyn B. Der diabetes mellitus. Wien: Alfred Holder, 1898.
[241] Brogard JM, Vetter T, Blickle JF. Discovery of pancreatic diabetes in Strasbourgh. Diabet Metab 1992;18(2):104-14.
[242] Caldwell J. Drug metabolism and pharmacogenetics: the British contribution to fields of international significance. Br J Pharmacol 2006;147(Suppl 1):S89-S99.
[243] Barach JH. Paul Langerhans, 1847-1888. Diabetes 1952;1(5):411-3.
[244] Campbell WR. Paul Langerhans, 1847-1888. Can Med Assoc J 1958;79(10):855-6.
[245] Becker V. 100 hundred years after Paul Langerhans’ doctoral thesis on the cells of the pancreas. Dtsch Med Wochenschr 1970;95(7):358-62. [German].
[246] Wolff G, Schadenwaldt H. 1877-1977: Bibliographic annotations on Paul Langerhans—the islands were his destiny. Med Welt 1977;28(1):1-7. [German].
[247] Ebling FJG. Homage to Paul Langerhans. J Invest Dermatol 1980;75:3-5.
[248] Sakula A. Paul Langerhans (1847-1888): a centenary tribute. J R Soc Med 1988;81(7):414-5.
[249] Jollies S. Paul Langerhans. J Clin Pathol 2002;55(4):243.
[250] Langerhans P. Beiträge zur mikroscopischen anatomie der bauchspeichel druse. Dissertation. Berlin: Gustav Lange, 1869. [German].
[251] Morrison H. Contributions to the microscopic anatomy of the pancreas by Paul Langerhans (Berlin, 1869). Reprint of the German original with an English translation and an introductory essay. Bull Inst Hist Med 1937;5:259-97.
[252] Fossati P. Edouard Laguesse at Lille in 1893 created the term “endocrine” and opened the endocrinology era. Hist Sci Med 2004;38(4):433-9. [French].
[253] Laguesse E. Sur la formation des ilots de Langerhans dans le pancreas. Comptes Rendus Hebdomadaires des Seances et Memoires de la Societe de Biologie 1893;5:819–820. [French].
[254] Laguesse E. Recherches sur l’histogénie du pancreas chez le mouton. J Anat Physiol 1895;31:475–500.
[255] Laguesse E. Sur la formation des ilots de Langerhans dans le pancreas. Comptes Rendus Hebdomadaires des Seances et Memoires de la Societe de Biologie 1893;5:819–20.
[256] Debeyre A. How insulin was discovered; corollary on the scientific research of the Dijon physician Gustave-Edouard Laguesse, former professor emeritus of the Lille Univeristy Medical faculty. Prog Med (Paris) 1956;84(23):442.
[257] Goet JP. Gustave Edouard Laguesse; his demonstration of the significance of the islands of Langerhans. Diabetes 1953;2(4):322-4.
[258] Dickinson WH. Diabetes. Disease of the kidney. London: Longsmans Green, 1875.
[259] von Mering JV, Minkowski O. Diabetes mellitus nach pankreasextirpation. Zbl Klin Med 1889;10:393-4. [German]
[260] Von Mering JV, Minkowski O. Diabetes mellitus nach pankreasexstirpation. Arch Pathol Pharmak 1889-1890;26:371-87. [German].
[261] Minkowski O. Die Lehre vom pancreas. Diabetes in ihrer geschichtlichen Entwicklung. Munch Med Wschr 1929;76:311-5. [Germna].
[262] No authors listed. Oskar Minkowski (1858-1931): designer of experimental diabetes. JAMA 1967;199:754-5.
[263] Kaiser W, Völker A. Oscar Minkowski (1858-1931). Z Gesamte Inn Med 1981;36(24):973-9. [German].
[264] Jörgens V. Oscar Minkowski (1858-1931): An outstanding master of diabetes research. Hormones (Athens) 2006;5(4):310-1.
[265] Brogard JM, Blickle JF. History of the rhenish and alsacian contributions to the understanding of diabetes. Hist Sci Med 2004;38(4):421-32. [French].
[266] Dittrich HM, Hahn Von Dorshe H. The anatomical and histological investigation of the pancreas in the 19th century and till the discovery of insulin (1921). The discovery of the pancreas-diabetes by von Mering and Minkowski (1889). Anat Anz 1978;143(5):509-17.
[267] Savona-Ventura C. The history of diabetes aellitus. A Maltese perspective. Malta: Self Publication, 2002. URL: http://staff.wm.edu.mt/csav1/books/diabetes_hist.pdf.
[268] Kidd JG. Eugene Lindsay Opie, MD, 1873-1971. Am J Pathol 1971;65(3):483-92.
[269] Olcott CT. Introductory remarks on the presentation of the twenty-first Middleton Goldsmith lecture. Bull Y Acad Med 1955;31(4):275-9.
[270] Menon S, Rajesh G, Balakrishman V. Pancreas and diabetes mellitus: The relationship between the organ and the disease. J Assoc Phys India 2015;63:).1-5.
[271] Opie EL. Ssobolew and insulin. Can Med Assoc J 1952;67(5):482.
[272] Opie EL. Pathological changes affecting the islands of Langerhans of the pancreas. J Boston Soc Med Soc 1900;4(10):251-60.
[273] Opie EL. On the relationship of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes mellitus. J Exp Med 1901;5(4):397-428.
[274] Opie EL. Diabetes mellitus associated with hyaline degeneration of the islands of Langerhans of the pancreas. Johns Hopkins Hosp Bull 1901;12(125):263 .
[275] Rous P. An inquiriy into certain aspects of Eugene L Opie. Arch Path 1942;34:1-6.
[276] Hughes J. Eugene L. Opie. Diabetes 1958;7(6):496-9.
[277] Hirsch JG. Eugene L. Opie, 1873-1971. Trans Assoc Am Physicians 1971;84:31-4.
[278] Ssobolew LW. Zur normalen und pathologishen Morphologie der inneren Secretion der Bauchspeicheldruse. Arch Pathol Anatomie Physiol Klin Med 1902; 168:91–128. [German].
[279] Granger A, Kushne JA. Ceulluar origins of cell regeneration: a legacy view of historical controversies. J Intern Med 2009;266(4):325-338. doi: 10.1111/j.1365-2796.2009.02156.x.
[280] Schulze W. Die Bedeutung der Langerhansschen Inseln im Paukreas. Arch Mikr Anat 1900;56:491–504. [German].
[281] Bayliss WM, Starling EH. The mechanism of pancreatic secretion. J Physiol 1902;28(5):325-53.
[282] Henriksen JH. Earnest Henry Starling (1866-1927): the scientist and the man. J Med Biogr 2005;13(1):22-30.
[283] Henriksen JH, Schaffalitzky de Muckadell OB. Secretin—the first hormone. Ugeskr Laeger 2002;164(3):320-5. [Danish].
[284] Scott RV, Tan TM, Bloom SR. Can Bayliss and Starling gut hormones cure a worldwide pandemic? J Physiol 2014;592(1):5153-67.
[285] Zuelzer GL. Über versuche einer specifischen fermentherapie des diabetes. Zeitshrift Exp Pathol Ther 1908;5:307-18. [German].
[286] Mellinghoff KH. Georg Ludwig Zuelzer’s contribution to the research on pancreatic extracts. Med Welt 1972;23(16):622-6. [German].
[287] Saudek CD. 2002 Presidential address: A tide in the affairs of medicine. Diabetes Care 2003;26(2):520-5.
[288] Bliss M. The discovery of insulin. Chicago, IL: Univ Chicago, 1982.
[289] Banting FG. Diabetes and insulin. Can Med Assoc J 1926;26(3):221-31.
[290] Lane MA. The cytological characters of the areas of Langerhans. Am J Anat 1907;7:409–22.
[291] Bensley RR. Studies on the pancreas of the guinea pig. Am J Anat 1911;12:297–388.
[292] Gupta V, Garg K, Raheja S, Choudhry R, Tuli A. The histogenesis of islets in the human fetal pancreas. J Anat Soc India 2002;51(1):23-6.
[293] Granger A, Kushner JA. Cellular origins of beta cell regeneration: a legacy view of historical controversies. J Intern Med 2009;266(4):325-38.
[294] Ferner H. The insular alpha and beta cells as the source of the antagonistic principles glucagon and insulin. Mikroskopie 1951;6(1–2):1–8.
[295] No authors listed. Sir Edward Sharpey-Schafer, FRS, LLD, MD, DSc, FRCPEd. BMJ 1935;1(3874):741-2.
[296] Schafer GMS. Sir Edward Sharpey-Schafer. BMJ 1935;1:801.
[297] Writer D. Resuscitation great. Sir Edward Sharpey-Schafer and his simple and efficient method of performing artificial respiration. Resuscitation 2004;61(2):113-6.
[298] Sykes AH. Edward Schafer (1850-1935) and artificial respiration. J Med Biogr 2006;14(3):155-62.
[299] No authors listed. Old age the the vices. Russell L Cecil. J Am Geriatrics Soc 1953;1:604.
[300] Textbook Titan. MD Magazine 1958;March:78-9.
[301] In sedication to Dr. Cecil”. Arthritis Rheuma 1963;6:vii-viii.
[302] In memoriam. Walsh McDermott (plus brief vita). Arthritis Rheuma 1965;8:577-80.
[303] McDermott W. Russell Lafayette Cecil. Trans Am Clin Climatol Assoc 1966;77:xlvi-xlvii.
[304] Cecil RL. On hypertrophy and regeneration of the islands of Langerhans. J Exp Med 1911;14(5):500-19.
[305] Cecil RL, Vaughan HF. Results of prophylactic vaccination against pneumonia at Camp Wheeler. J Exper Med 1919;29:457–83.
[306] Cecil RL, Larsen NP. Clinical and bacteriologic study of one thousand cases of lobar pneumonia. JAMA 1922;79:343–9.
[307] Cecil RL, Sutliff WD. The treatment of lobar pneumonia with concentrated anti-pneumococcus serum. JAMA 1928;91:2036–40.
[308] Cecil RL, Plummer N. Pneumococcus Type 1 pneumonia: a study of eleven hundred and sixty-one cases, with especial reference to specific therapy. JAMA 1931;95:1547–53.
[309] Neuhauser D, Diaz M, Chalmers I. A puzzling omission in a gret medical textbook edited by a pioneer of controlled trials. J R Soc Med 2008;101(7):381-383.
[310] Cecil RL. Textbook of medicine. Philadelphia, PA: WB Saunders, 1927.
[311] Goldman L, Schafer AI, eds. Goldman-Cecil medicine, 25th ed. Philadelphia, PA: Elsevier, 2016.
[312] Scott EL. The relation of pancreatic extract to the sugar in the blood. Proc Soc exp Med Biol 1913;10:101-3.
[313] Boehm R, Hoffmann FA. Beiträge zur Kentniss des Kohlehydratsoff- wechsels. Arch Exp Pathol Pharmakol 1878;8:295-304. [German].
[314] Macleod JJR. Studies in experimental glycosuria: I. On the existence of afferent and efferent nerve fibers, controlling the amount of sugar in the blood. Am J Physiol 1907;19:388-406.
[315] Drinker CK. Walter Bradford Cannon 1871-1945. Science 1945; 102(2654):470-2.
[316] Iaroshevskiĭ MG. Chesnokova SA. Centenary of the birth of Walter Bradford Cannon (1871-1945). Fiziol Zh SSSR Im I M Sechenova 1971;57(10):1559-62. [Russian].
[317] Joaquin Izquierdo J. Walter Bradford Cannon (1871-1945). His human general personality. In memoriam. Gac Med Mex 1972;104(1):73-6. [Spanish].
[318] Gorisch E, Gorisch R. Walter Bradford Cannon (1871-1945). The professional activities of an outstanding physiologist. Z Gesamte Hyg 1990;36(7):368-70. [German].
[319] Cooper SJ. From Claude Bernard to Walter Cannon. Emergence of the concept of homeostatis. Appetite 2008;51(3):419-27.
[320] Cannon WB, Shohl AT, Wright WS. Emotional glucosuria. Am J Physiol 1911;29:280-7.
[321] Cannon WB. The secretion of the adrenal glands during emotional excitement. Science 1911;2:907.
[322] Henderson Y, Underhill FP. Acapnia and glycosuria. Am J Physiol 1911; 28:275-89.
[323] Knox WE. Sir Archibald E Garrod. Genetics 1967;56(1):1-6.
[324] Dronamraju K. Profiles in genetics: Archibald E. Garrod (1857-1936). Am J Hum Genet 1992;51(1):216-9.
[325] Garrod AE. Lettsomian lectures on glycosuria. Lancet 1912;1:480-8.
[326] Folin O, Denis W, Smillie WG. Some observations on “emotional glycosuria” in man. J Biol Chem 1914;17:519-20.
[327] Allen FM. Studies concerning glycosuria and diabetes, Cambridge, MA: Harvard University Press, 1913.
[328] Allen FM, Stillman E, Fitz R. Total dietary regulation in the treatment of diabetes. New York: Rockefeller Institute Medical Research, Monograph 11, 1919.
[329] Duncan GG. Frederick Madison Allen 1879-1964. Diabetes 1964;13:318-9.
[330] No authors listed. Frederick Madison Allen 1879-1964. Metabolism 1964;13:383-5.
[331] Grott JW, Swiezawska E. Frederick Madison Allen (1879-1964) and his contributions to the knowledge of diabetes mellitus. Pol Tyg Lek 1965;20(49):1872. [Polish].
[332] Mazur A. Why were “starvation diets” promoted for diabetes in the pre-insulin period? Nutr J 2011;10:23. doi: 10.1186/1475-2891-10-23.
[333] Westman EC, Yancy WS Jr., Humphreys M. Dietary treatment of diabetes mellitus in the pre-insulin era (1914-1922). Perspect Biol Med 2006;49(1):77-83.
[334] Barnett DM. Elliot Proctor Joslin. American National Biography. New York: Oxford Press, 1999:282–83.
[335] Joslin EP. The obligation and the opportunity of the chiropodist in the treatment of diabetes. J Am Podiatr Med Assoc 2007;97(4):271-3.
[336] Joslin EP. Influence of bile on metabolism. J Boston Soc Med Sci 1899;3(10):259-63.
[337] Joslin EP. Present day treatment and prognosis in diabetes. Am J Med Sci 1915;150:485-96.
[338] Beaser RS, Campbell A. The Joslin guide to diabetes. Boston, MA: Joslin Diabetic Center, 2016.
[339] Kleiner IS, Meltzer SJ. Retention in the circulation of dextrose in normal and depancreatized animsl and the effects of an intravension injection of an emulsion of pancreas upon this retention. Proc Nat Acad Sc 1915;1:338-40.
[340] Kleiner IS. The actions of the intravenous injections of pancreatic emulsions in experimental diabetes. J Biochem 1919;40:153-70.
[341] Kleiner IS. The action of intravenous injections of pancreas emulsions in experimental diabetes. Am J Physiol 1919;29:306-10.
[342] Barthold SW. Unsung heroes in the battle against diabetes. ILAR J 2004;45(3):227-30.
[343] Tattersal R. Pancreatic organotherapy for diabetes, 1889-1921. Med Hist 1995;39(3):288-316.
[344] James T. History of medicine. Paulesco. S Afr Med J 1992;82(2):123-5.
[345] Dominguez LJ, Licata G. The discovery of insulin: what really happened 80 years ago. Ann Ital Med Int 2001;16(3):155-62. [Italian].
[346] Laron Z. Nicolae C. Paulescu—scientist and politician. Isr Med Assoc J 2008;10(7):491-3.
[347] Paulesco NC. Action de l’extrait pancreatique injecte dans le sang, chez un animal diabetique. Comptes Rendus des Seances de la Societe de Biologie 1921;85:555–9. [French].
[348] D Haulica I. Professor Nicolae C. Paulesc-the true discoverer of insulin. Rev Med Chir Soc Med Nat Iasi 2001;105(3):602-5. [Romanian].
[349] Roth J, Qureshi S, Whitford I, Vranic M, Kahn CR, Fantus IG, et al. Insulin’s discovery: new insights on its ninetieth birthday. Diabetes Metab Res Rev 2012;28(4):293-304.
[350] Bliss M. The eclipse and rehabilitation of JJR Macleod, Scotland’s insulin laureate. J R Coll Physicians Edinb 2013;43(4):366-73.
[351] Pavel I, Sdrobici D. N. Paulescu, discoverer of insulin. 50th anniversary of the discovery of that hormone. Med Interna (Bucur) 1972;24(11):1285-94. [Romanian].
[352] Kenéz J. Who invented insulin? (Charles H. Best, Frederick Grant Banting). Orv Hetil 1978;119(44):2693-9. [Hungarian]
[353] No authors listed. Frederick Grant Banting (1891-1941), codiscovered of insulin. JAMA 1966;198(6):660-1.
[354] Raju TN. A mysterious something: the discovery of insulin and the 1923 Nobel Prize for Frederick G Banting (1891-1941) and John JR Macleod (1876-1935). Acta Paediatr 2006;95(10):1155-6.
[355] Berche P, Lefrère JJ. The return to life with insulin. Ann Endocrinol (Paris) 2010;71(4):243-8. [French][356] De Herder WW. Heroes in endocrinology: Nobel Prizes. Endocr Connect 2014;3(3):R94-R104.
[357] Pai-Dhungat JV, Parikh F. Frederick Banting (1891-1941). J Assoc Physicians India 2015;63(3):114.
[358] Barron M. The relation of the islets of Langerhans to diabetes with special reference to cases of pancreatic lithiasis. Surg Gynec Obstet 1920;31:437–448.
[359] Hobart A, Reimann MD. Moses Barron and Banting. JAMA 1967;199(1):48.
[360] Shampo MA, Kyle RA. Charles Best—codiscoverer of insulin. Mayo Clin Proc 2004;79(12):1546.
[361] Macleod J. Insulin and diabetes. BMJ 1922;2:833.
[362] Macleod JJR: History of the researches leading to the discovery of insulin (1922), letter of Macleod to Col. Albert Gooderham. Bull History Med 1978;52:295-312.
[363] Shampo MA, Kyle RA. Macleod John J.R.--Nobel prize for discovery of insulin. Mayo Clin Proc 2006;81(8):1006.
[364] Banting FG, Best CH. Pancreatic extracts. J Lab Clin Med 1922;7:464–72.
[365] Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA. Pancreatic extracts in the treatment of diabetes mellitus. Preliminary report. Can Med Assoc J 1922;12:141–146.
[366] Noble RL. Memories of James Bertram Collip. Can Med Assoc J 1965; 93(26):1356-1364.
[367] Barr ML, Rossiter RJ. James Bertram Collip 1892-1965. Biogr Mem Fellows R Soc 1973;19:234.
[368] Bangham DR. H.H. Dale and the London Centre for WHO standards—some milestones of the early years. Dev Biol Stand 1999;100:11-5.
[369] Harvey AM. Pharmacology’s giant: John Jacob Abel. Johns Hopkins Med J Suppl 1974;135(4):245-58.
[370] Murnaghan JH, Talalay P. John Jacob Abel and the crystallization of insulin. Perspect Biol Med 1967;10(3):334-80.
[371] Himsworth HP. Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Diabet Med 2011;28(12):1440-4. (Reprinted from Management of diabetes mellitus, BMJ 1936).
[372] Black D, Gray J. Sir Harold Percival Himsworth, K.C.B.-19 May 1905—1 November 1993. Biogr Mem Fellows R Soc 1995;41:199-218.
[373] Himsworth R. Sir Harold Himsworth. Diabet Med 2011;28(11):1438-9.
[374] Krentz AJ, Hitman GA. Sir Harold Himsworth and insulin insensitivity 75 years on. Diabet Med 2011;28(12):1435.
[375] Sanger F. The free amino groups of insulin. Biochem J 1945;39(5):507-15.
[376] Sanger F, Thompson EO, Kitai R. The amide groups of insulin. Biochem J 1955;59(3):509-18.
[377] Sanger F. Chemistry of insulin: determination of the structure of insulin opens the way to greater understanding of life processes. Science 1959;129(3359):1340-4.
[378] Deckert T. Hans Christian Hagedorn (1888-1971). Ugeskr Laeger 2007;169(35):2883. [Danish].
[379] Poulsen JE. Hans Christian Hagedorn (1888-1971. Dan Medicinhist Årbog 1978;9-45. [Danish].
[380] Kruse PR. The hospital pharmacies in Copenhagen and their professional importance. Dan Medicinhist Årbog 2005;33:163-70. [Danish].
[381] Philipson LH, Bell G, Polonsky KS. Donald F. Steiner MD, 1930-2014: Discoverer of proinsulin. PNAS (Proc Nat Acad Sci) 2015;112(4):940-1.
[382] Frandsen CS, Dejgaard TF, Madsbad S. non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus. Lancet Diabetes Endocrinol 2016 Mar 8. pii: S2213-8587(16)00039-5.
[383] Kooti W, Farokhipour M, Asadzadeh Z, Ashtary-Larky D, Asadi-Samani M. The role of medicinal plants in the treatment of diabetes; a systematic review. Electron Physician 2016;8(1):1832-42.
[384] Röder PV, Wu B, Liu Y, Han W. Pancreatic regulation of glucose homeostasis. Exp Mol Med 2016;48:e219.
[385] Salas-Salvado J, Guasch-Ferré M, Lee CH, Estruch R, Clish CB, Ros E. Protective effects of the Mediterranean diet on type 2 diabetes and metabolic syndrome. J Nutr 2016 Mar 9. pii:jn218487.
[386] Voormolen DN, Abell SK, James R, Hague WM, Mol BW. Diagnostic criteria and treatment for gestational diabetes mellitus. Semin Reprod Med 2016;34(2):102-9.
[387] Luczynski W, Glowinska-Olszewska B, Bossowski A. The influence of clinical and genetic factors on the development of obesity in children with type 1 diabetes. Diabetes Metab Res Rev 2016 Mar 6. doi: 10.1002/dmrr.2797.
[388] Backes JM, Kostoff MD, Gibson CA, Ruisinger JF. Statin-assocviated diabetes mellitus: review and clinical guide. South Med J 2016;109(3):167-73.
[389] Brunström M, Carlberg G. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ 2016 Feb 24;352:i717. doi: 10.1136/bmj.i717.
[390] Knip M, Siljander H. The role of the intestinal microbiota in type 1 diabetes mellitus. Nat Rev Endocrinol 2016;12(3):154-67.
[391] Clements JN, Bello L. Insulin glargine 300 units/mL: a new basal insulin product for diabetes mellitus. Am J Health Syst Pharm 2016;73(6):359-66.
[392] Barnosky A, Shah L, Meah F, Emanuele N, Emanuele MA, Mazhari A. A primer on concentrated insuins: what an internist should know. Postgrad Med 2016 Feb 27.
[393] Dholakia S, Mittal S, Quiroga I, Gilbert J, Sharples E, Pleog RF et al. Pancreas transplantation: past, present, future. Am J Med 2016 Mar 7. pii; S0002-9343(16)30199-1.
[394] Jewett EA, Anderson MR, Gilchrist GS. The pediatric subspecialty workforce: public policy and forces for change. Pediatrics 2005;116(5):1192-202.
[395] Pierce JS, Kozikowski C, Lee JM, Wysocki T. Type 1 diabetes in very young children: a model of parent and child influences on management and outcomes. Pediatr Diabetes 2015 Dec 29. doi: 10.1111/pedi.12351.
[396] Kim SH. Maturity-onset diabetes of the young: what do clinicians need to know? Diabetes Metab J 2015;39(6):468-77.
[397] Greydanus DE. Endocrine disorders. In: Hofman AD, ed. Adolescent medicine. Menlo Park, CA: Addison-Wesley, 1983:160-80.
[398] Greydanus DE, Hofmann AD. Endocrine disorders. In: Hofman AD, Greydanus DE, eds. Adolescent medicine, 2nd ed. Norwalk, CT: Appleton Lange, 1989:231-56.
[399] Greydanus DE. Exercise and insulin-requiring diabetes mellitus. In: Luckstead EF, Greydanus DE, eds. Medical care of the adolescent athlete. Los Angeles, CA: Professional Medical Information, 1993:177-8.
[400] Greydanus DE. Endocrine disorders. In: Hofman AD, Greydanus DE, ds. Adolescent medicine, 3rd ed. Norwalk, CT: Appleton Lange, 1997:314-47.

You have not viewed any product yet.


SHOW ALL OF MY RECENTLY VIEWED BOOKS